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Abstract
Adipose tissue engineering holds promise to address the unmet need in plastic and reconstructive
surgery for strategies that promote the stable and predictable regeneration of adipose tissue for
volume augmentation applications. Previous studies have demonstrated that decellularized
adipose tissue (DAT) scaffolds can provide a pro-adipogenic microenvironment, and that seeding
with adipose-derived stromal cells (ASCs) can enhance in vivo angiogenesis and adipogenesis
within DAT implants. Recognizing that bioreactor systems can promote cell expansion and
infiltration on tissue-engineered scaffolds, this study evaluated the effects of culturing human
ASCs on DAT scaffolds within a perfusion bioreactor. Using this system, the impact of both
shear stress stimulation and hypoxic preconditioning were explored in vitro and in vivo. Initial
studies compared the effects of 14 days of culture within the perfusion bioreactor under 2% O2 or
~20% O2 on human ASC expansion and hypoxia inducible factor 1 alpha (HIF-1α) expression in
vitro relative to static cultured controls. The findings indicated that culturing within the
bioreactor under 2% O2 significantly increased ASC proliferation on the DAT, with a higher cell
density observed in the scaffold periphery. HIF-1α expression was significantly higher when the
scaffolds were cultured under 2% O2. Subsequent characterization in a subcutaneous implant
model in athymic nude mice revealed that in vivo angiogenesis and adipogenesis were markedly
enhanced when the ASCs were cultured on the DAT within the perfusion bioreactor under 2%
O2 for 14 days prior to implantation relative to the other culture conditions, as well as additional
freshly-seeded and unseeded DAT control groups. Overall, dynamic culture within the perfusion
bioreactor system under hypoxia represents a promising approach for preconditioning ASCs on
DAT scaffolds to enhance their capacity to stimulate blood vessel formation and infiltration, as
well as host-derived adipose tissue regeneration.
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Introduction
The subcutaneous adipose tissue layer plays important structural and functional roles within the
integumentary system1. Due to the limited capacity of adipose tissue for self-repair, damage or
loss resulting from trauma, burns, tumour resections, disease or aging can alter the normal body
contours and result in scarring, deformities and loss of function2. While reconstruction can have
a major positive impact on self-image and quality of life, there are numerous limitations to the
existing clinical interventions that rely on tissue transfer from other sites on the body or on
current implants used for volume augmentation3,4.
Adipose tissue engineering represents a promising approach to address the unmet clinical need in
plastic and reconstructive surgery for strategies that can promote the stable regeneration of
healthy host-derived soft tissues5,6. Towards this goal, our lab has pioneered the development of
off-the-shelf bioscaffolds derived from human decellularized adipose tissue (DAT),
demonstrating that they provide a pro-adipogenic microenvironment both in vitro and in vivo7,8.
DAT contains a diverse array of extracellular matrix (ECM) components, including a variety of
matricellular proteins, small leucine-rich proteoglycans (SLRPs), growth factors and
chemokines9 that may have bioactive effects on seeded and infiltrating host cell populations.
Moreover, the DAT has similar biomechanical properties to native human fat10,11, which may be
favorable for both implant integration and adipogenic differentiation7,12.
Previously, we demonstrated that seeding the DAT with allogeneic adipose-derived stromal cells
(ASCs) enhanced angiogenesis and adipogenesis within the implants in an immunocompetent
Wistar rat model13. More specifically, our study suggested that the ASCs indirectly contributed
to host-derived adipose tissue regeneration through paracrine mechanisms, rather than through
long-term engraftment and differentiation. It is well-established that ASCs secrete a variety of
1
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pro-regenerative growth factors and cytokines that can promote the recruitment of host
progenitor cells, stimulate angiogenesis, and modulate the response of infiltrating immune cell
populations, to help coordinate tissue regeneration14–16.
A key limitation to the previous approach was that the static seeding and culture methods
employed resulted in low cellular infiltration and a heterogeneous distribution of the ASCs
within the dense ECM of the DAT, which may have limited their long-term survival and
functionality following in vivo implantation. As such, the primary goal of this study was to
explore the potential of dynamic culture as a strategy to enhance human ASC expansion,
infiltration and pro-regenerative function on the DAT bioscaffolds. In particular, perfusion
bioreactors represent a promising approach for promoting cell growth on 3-D bioscaffolds by
enhancing nutrient delivery and waste removal17,18. Further, the shear forces applied by these
systems can modulate cell phenotype and function19–22, which may alter their capacity to
stimulate regeneration.
In the current experimental design, human ASCs were pre-seeded on the DAT under dynamic
conditions on an orbital shaker and then transferred into a custom-designed perfusion bioreactor
system and cultured for 14 days. As oxygen tension has been shown to modulate ASC survival23,
proliferation24, differentiation25,26, and pro-angiogenic factor production14,27,28 through the
regulation of hypoxia inducible factor-1 alpha (HIF-1α)29–31, we explored the effects of culturing
the cells under both normoxic (~20% O2) and hypoxic (2% O2) conditions. The selection of
2% O2 was based on studies showing enhanced ASC expansion in vitro at this level25,32. Initial
studies focused on characterizing human ASC distribution, proliferation, and HIF-1α expression
in vitro relative to control scaffold groups cultured under static conditions. Subsequently, in vivo
testing was performed to probe the effects of dynamic culture within the perfusion bioreactor on
2
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human ASC retention, angiogenesis and adipogenesis within a subcutaneous implant model in
athymic nude (nu/nu) mice relative to static cultured, freshly-seeded and unseeded DAT scaffold
controls.

Methods
Materials
Unless otherwise stated, all chemicals and reagents were purchased from Sigma Aldrich Canada
Ltd. (Oakville, Canada), and all antibodies were purchased from Abcam (Cambridge, USA).
Adipose tissue processing
Subcutaneous adipose tissue was collected with informed consent from elective breast reduction
or abdominoplasty surgeries at the University Hospital and St. Joseph’s Hospital in London,
Canada. All studies were approved by the Human Research Ethics Board at Western University
(HREB# 105426). The tissues were transported on ice in sterile phosphate buffered saline (PBS)
with 2% bovine serum albumin (BSA) and processed within 2 h of collection for ASC isolation33
or DAT scaffold fabrication7 using published protocols.
ASCs were cultured in proliferation medium comprised of DMEM:Ham’s F12 supplemented
with 10% fetal bovine serum (FBS) (Wisent, St. Bruno, Canada) and 100 U/mL penicillin/0.1
mg/mL streptomycin (1% pen-strep) (ThermoFisher, Waltham, USA) at 37°C with 5% CO2 and
~20% O2. Freshly isolated cells were passaged at 80% confluence, and passage 3 (P3) cells were
used in all studies.
Following decellularization, the DAT was lyophilized and cut into scaffolds with a mass of 8 ± 1
mg. In preparation for seeding, the DAT scaffolds were rehydrated in deionized water for 24 h
3
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and then decontaminated by repeated rinsing in 70% ethanol. Next, the scaffolds were rinsed in
sterile PBS and incubated in proliferation medium for 24 h.
Scaffold seeding and bioreactor setup
To seed the scaffolds, 1 x 106 P3 human ASCs were combined with individual DAT scaffolds in
3 mL of proliferation medium within 15 mL vented cap conical tubes (CellTreat Scientific
Products, Pepperell, USA). The tubes were transferred into an incubator and agitated on an
orbital shaker at a 15° incline and 100 RPM for 24 h (37°C, 5% CO2). Following seeding, the
scaffolds were transferred into culture inserts that could be positioned within the individual
sample chambers of the customized perfusion bioreactor system (Tissue Growth Technologies,
Instron) (Supplemental Figure 1). The cell-seeded scaffolds were cultured under a flow rate of
0.5 mL/min for 14 days in proliferation medium under either normoxic (~20% O2: 5% CO2/95%
air) or hypoxic (5% CO2/93% N2/2% O2) conditions, controlled through the use of a tri-gas
incubator (ThermoFisher Forma Series II 3130), at 37°C. Static control scaffolds were included
by culturing within the inserts under static conditions within vented cap conical tubes.
Assessment of ASC density and distribution
After 14 days of culture, scaffold samples were collected (n=4 replicate scaffolds/trial, N=3 trials
with different ASC donors) for analysis of total cell density using the Quant-iT® PicoGreen®
dsDNA Assay Kit (ThermoFisher, Waltham, USA). For all trials, control groups were included
of freshly-seeded (collected after the 24 h dynamic seeding phase) and unseeded DAT scaffolds.
The scaffolds were finely minced with surgical scissors and digested in 1 mL of 4 mg/mL
collagenase (Worthington Type I) in Kreb’s Ringer Buffer supplemented with 1% BSA, 2 mM
glucose, and 25 mM HEPES under agitation at 100 RPM on an orbital shaker for 1 h at 37°C.

4
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The digested scaffolds were then centrifuged for 10 min at 1200 xg at room temperature,
resuspended in Tris-EDTA buffer (10 mM Tris base, 1 mM EDTA, pH 8), and briefly sonicated
using an ultrasonic dismembrator (ThermoFisher Model 100). The samples were then
centrifuged at 5000 xg for 10 min at room temperature to remove debris, and the supernatant was
analyzed using the PicoGreen® Assay kit according to the manufacturer’s instructions using a
CLARIOstar® microplate reader (BMG Labtech, Guelph, Canada). All plates included a standard
curve generated with known numbers of ASCs to estimate the total number of ASCs per
scaffold.
To corroborate the PicoGreen® data, the density of ASCs on the scaffolds was also assessed after
14 days of culture through quantification of DAPI staining (n=3, N=3). Scaffold samples were
fixed in 4% paraformaldehyde for 24 h at 4°C before being embedded in paraffin and cut into
7 µm sections. Three non-adjacent cross-sections 100 µm apart were stained with DAPI,
mounted and imaged with an EVOS® FL Cell Imaging System (ThermoFisher) under the 20X
objective. DAPI+ cells from 10 randomly selected non-adjacent fields from each scaffold crosssection were quantified using ImageJ software.
Hematoxylin & eosin (H&E) staining was also performed on scaffold cross-sections following
standard procedures to assess the cell distribution within the DAT scaffolds after 14 days of
culture (n=4, N=3). The samples were visualized using an EVOS® XL Cell Imaging System
(ThermoFisher).
Immunohistochemical analysis of Ki-67 and HIF-1α expression
Immunohistochemical staining was performed on additional scaffold sections (3 non-adjacent
sections at least 100 µm apart/scaffold; n=3, N=4) to examine the expression of Ki-67 as a

5
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proliferation marker and HIF-1α to probe potential changes under hypoxia. Heat-mediated
antigen retrieval was performed in target antigen retrieval solution (Agilent, Santa Clara, USA)
for 25 min. The slides were allowed to cool for 25 min and then washed in PBS and blocked in
PBS-T (0.1% Tween-20) supplemented with 10% goat serum for 1 h at room temperature.
Sections were then incubated with rabbit anti-Ki-67 antibody (1:100 dilution) or mouse anti-HIF1α antibody (Novus Biologicals, Oakville, Canada; 1:100 dilution) overnight at 4°C. Alexa
Fluor® 594 conjugated goat anti-rabbit (1:100 dilution) or Alexa Fluor® 680 conjugated goat
anti-mouse (1:100 dilution) secondary antibody was subsequently applied for 1 h at room
temperature and the samples were mounted in Fluoroshield Mounting Medium with DAPI
(Abcam, Cambridge, USA). Stained sections were visualized with the EVOS® FL Cell Imaging
System, and 10 randomly selected non-adjacent fields of view from both the peripheral (< 200
µm from the scaffold edge) and central (>200 µm from the scaffold edge) regions of the
scaffolds were imaged under the 20X objective. The number of Ki-67+DAPI+ cells and
HIF-1α+DAPI+ within each region were quantified using ImageJ Software.
Subcutaneous implantation surgeries
Following the in vitro testing, studies were performed to assess the effects of bioreactor culture
on the capacity of the human ASCs to stimulate in vivo angiogenesis and adipogenesis within the
DAT scaffolds. More specifically, these studies compared 6 scaffold groups including the ASCseeded scaffolds that had been cultured for 14 days within the perfusion bioreactor or under
static conditions at both 20% and 2% O2 (i.e. (i) 20% O2 static, (ii) 20% O2 dynamic, (iii) 2% O2
static, (iv) 2% O2 dynamic) to (v) freshly-seeded (after the 24 h seeding phase) and (vi) unseeded
DAT scaffold controls. For each scaffold group, duplicate samples were implanted for each trial
and a total of 3 trials were performed using ASCs isolated from 3 different donors. All studies
6
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followed the Canadian Council on Animal Care (CCAC) guidelines and the protocols were
approved by the Animal Care Committee at Western University (Protocol # 2015-049).
The scaffolds were implanted subcutaneously in female Nu-Foxn1nu mice (Charles River
Laboratories, Sherbrooke, Canada) that were 10-13 weeks of age for 4 and 8 weeks. A total of 36
mice were used for this study (N=6 mice per scaffold group at each timepoint). The mice were
anaesthetized with isoflurane and given pre-operative analgesics via subcutaneous injections of
meloxicam (2 mg/kg loading dose; 1 mg/kg follow up dose at 24 h) and bupivacaine (2 mg/kg).
Two small incisions (~7 mm) were made on the dorsa of each mouse below each scapula, and
pockets were created using blunt-ended forceps. One scaffold was then carefully positioned
within each pocket and the incisions were closed with surgical staples. At each timepoint, the
mice were euthanized by CO2 overdose and the scaffolds were excised within their surrounding
tissues. The samples were fixed in 4% paraformaldehyde overnight at 4°C, prior to paraffin
embedding and sectioning (7 µm thick) in preparation for histological and immunohistochemical
analyses. For all staining analyses, 3 cross-sections per implant (N=6 per time point) were
analyzed that were a minimum of 100 µm apart.
Masson’s trichrome staining
Masson’s trichrome staining was performed using standard procedures to assess implant
integration and remodeling, as well as the density of erythrocyte-containing blood vessels within
the scaffolds. The entire scaffold cross-section in each sample was imaged using the EVOS® XL
Cell Imaging System at 20X magnification and combined into a single cross-sectional image
using Adobe® Photoshop® CS6 Software. Within each complete cross-section, the number of
erythrocyte-containing blood vessels was quantified within the DAT implant to determine the
overall blood vessel density. Further, the distance to the closest scaffold edge and diameter were
7
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measured for each vessel using ImageJ Software. Vessel infiltration within 500 µm of the
scaffold surface was analyzed using frequency distribution graphs with a bin size of 25 µm.
Immunohistochemical analysis of perilipin expression
At both timepoints, immunohistochemical staining was performed to assess perilipin expression
as a marker of adipocyte formation within the DAT implants. The sections were prepared as
described above and incubated overnight in rabbit anti-perilipin A antibody (1:200 dilution) at
4°C, followed by a goat anti-rabbit HRP-conjugated secondary antibody (1:500 dilution) for 1 h
at room temperature. The samples were then processed with a DAB peroxidase (HRP) substrate
kit (Vector Labs, Burlington, Canada), followed by counterstaining with hematoxylin and
mounting with Permount® Mounting Medium (ThermoFisher, Waltham, USA). The entire
scaffold region was imaged at 10X magnification and stitched into a single cross-sectional image
as previously described. Positive pixel counting was performed to analyze the relative perilipin
expression levels between the implant groups, with the values normalized to the total scaffold
area within each cross-section measured using ImageJ Software.
Immunohistochemical analysis of human ASC engraftment and differentiation
To detect the human ASCs within the DAT implants, cross-sections were stained for humanspecific Ku8034 using a rabbit anti-Ku80 antibody (Cedarlane, Burlington, Canada; 1:100
dilution) followed by Alexa Fluor® 594 conjugated goat anti-rabbit (1:200 dilution) secondary
antibody as described above. The stained cross-sections were imaged using the EVOS® FL Cell
Imaging System. Quantification of Ku80+DAPI+ cells was performed on 10 randomly selected
non-overlapping fields of view taken at 20X magnification using ImageJ analysis software.

8
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To probe whether the human ASCs were differentiating into adipocytes within the DAT implant
region, co-staining was performed using rabbit anti-perilipin A antibody as an adipocyte marker
in combination with a mouse anti-human mitochondria (hMito) antibody conjugated with Cy3
(EMD Millipore, Burlington, USA; 1:100 dilution). hMito was used as an alternative to Ku80
based on the availability of antibodies compatible for co-staining. The samples were incubated
overnight at 4°C and then incubated for 1 h at room temperature with a goat anti-rabbit
secondary antibody conjugated with Alexa Fluor® 680 (1:100 dilution). The stained sections
were visualized with the EVOS® FL Cell Imaging System and imaged under 20X magnification.

Statistical analysis
All numerical values are represented as the mean ± standard deviation. Statistical analyses were
performed using GraphPad Prism® version 6 by one way or two-way ANOVA and followed by a
Tukey’s post-hoc test. Differences were considered statistically significant at p<0.05.

Results
Dynamic culturing in the bioreactor under hypoxic conditions for 14 days enhanced ASC density
on the DAT bioscaffolds
To quantitatively assess cell density on the DAT, the scaffolds were digested and analyzed with
the PicoGreen® dsDNA Assay. Freshly-seeded scaffolds had an average of 1.49 ± 0.19 x 105
cells per scaffold following the 24 h seeding period. After 14 days of culture, the total cell
density was significantly higher in the 2% O2 dynamic group as compared to the freshly-seeded
scaffolds and the 20% O2 static and 2% O2 static groups (Figure 1A). DAPI staining showed
9
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similar patterns in terms of the ASC density on the DAT scaffolds, corroborating the PicoGreen®
results (Figure 1B).
To complement the quantitative findings, H&E staining was performed to assess the ASC
distribution within the DAT scaffolds following the 14-day culture period. The ASCs were
predominantly localized to the surface of the DAT scaffolds in the samples that were cultured
under static conditions at both 20% and 2% O2 (Figure 1C). A higher density of ASCs was
observed in the scaffolds cultured for 14 days within the bioreactor, with a dense cell layer
observed along the surface of the scaffolds. Consistent with the PicoGreen® results, the 2% O2
dynamic group appeared to have a qualitatively higher density of cells, with greater infiltration
into the central scaffold regions.
Dynamic culturing in the bioreactor under hypoxic conditions for 14 days enhanced Ki-67
expression in the scaffold periphery
Immunostaining identified a low density of Ki-67+DAPI+ cells distributed throughout the
scaffolds at 14 days. Qualitatively, there appeared to be more Ki-67+DAPI+ cells in the 2% O2
dynamic group, with a higher density in the scaffold periphery (Figure 2A). Representative
images of the central scaffold regions are shown in Supplemental Figure 2. These observations
were confirmed by quantification of the number of Ki-67+DAPI+ cells within the peripheral
(< 200 µm from edge) and central (> 200 µm from edge) regions of the scaffolds, which
revealed that there was a significantly higher density of Ki-67+DAPI+ cells in the periphery in the
2% O2 dynamic group as compared to both the peripheral and central regions of all other culture
conditions. Additionally, a greater density of Ki-67+DAPI+ cells was measured in the central
region of 2% O2 dynamic group as compared to the central region of 2% O2 static group (Figure
2B).
10
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Culturing under hypoxia increased the number of HIF-1α+ cells within the scaffolds at 14 days
Immunohistochemical staining revealed that there were very few HIF-1α+DAPI+ cells in both the
peripheral (< 200 µm from edge) and central (> 200 µm from edge) regions of the scaffolds
cultured either dynamically or statically for 14 days under 20% O2 (Figure 3A). In contrast,
HIF-1α expression was observed in the majority of the cells in the 2% O2 static and dynamic
groups. Representative images of the central scaffold regions are shown in Supplemental Figure
3. Quantification of the staining indicated that the density of HIF-α+DAPI+ cells was significantly
higher in the 2% O2 dynamic group as compared to all other groups within both the peripheral
and central scaffold regions (Figure 3B). In addition, the density of HIF-1α+ DAPI+ cells was
also significantly greater in the 2% O2 static group as compared to the 20% O2 static and
dynamic groups within both the peripheral and central scaffold regions (Figure 3B).
DAT scaffolds cultured within the bioreactor for 14 days under hypoxic conditions showed
enhanced blood vessel formation at 4 and 8 weeks following subcutaneous implantation
In vivo studies were subsequently performed using a subcutaneous implantation model in nu/nu
mice to compare angiogenesis and adipogenesis in the scaffolds that had been cultured for 14
days within the bioreactor or statically (20% O2 static, 20% O2 dynamic, 2% O2 static, 2% O2
dynamic) to freshly-seeded and unseeded controls. Masson’s trichrome staining at 4 and 8 weeks
revealed that the scaffolds were well integrated into the host tissues and showed evidence of
implant remodeling (Figure 4A). Small blood vessels and adipocytes were observed in the
peripheral regions of the DAT implants starting at 4 weeks. At 8 weeks, more vessels were
observed in the 2% O2 dynamic group as compared to all other conditions, along with a greater
number of adipocytes extending into the more central scaffold regions (Figure 4A).

11
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Quantification of the number of erythrocyte-containing blood vessels in the scaffolds revealed
that there was a significantly higher vessel density in the 2% O2 dynamic group as compared to
all other conditions at both 4 and 8 weeks (Figure 4B), with a significant difference between the
two timepoints for this group. Further, the vessel density in the 20% O2 dynamic group at 8
weeks was significantly greater than the unseeded, freshly-seeded and 20% O2 static groups at
both 4 and 8 weeks. The diameter of the erythrocyte-containing blood vessels was also
measured, with results indicating that there were no significant differences in the average
diameter between the groups at both 4 and 8 weeks, with an average diameter in the range of
~25 - 35 µm (Supplemental Figure 4A).
Blood vessel infiltration was also probed by measuring the shortest distance from each vessel to
the scaffold periphery. No significant difference in the average distance of blood vessel
infiltration was measured between the groups at 4 weeks, with the average values ranging from
~70 - 125 µm and a high degree of variability observed (Supplemental Figure 4B). At 8 weeks,
the average distance of vessel infiltration was significantly higher in the 2% O2 dynamic group
(198.8 ± 32.1 µm) as compared to all other groups with the exception of the 20% O2 static
(100.7 ± 38.3 µm) and 20% O2 dynamic (125.1 ± 46.6 µm) groups.
Vessel infiltration within 500 µm of the scaffold surface was further analyzed by frequency
distribution plots with pooled counts of the total number of vessels within 25 µm intervals for
each of the scaffold groups (Figure 5). Based on this analysis, an increase in the number of
vessels within the first 100 µm of the scaffolds was observed in the 2% O2 dynamic and static
groups at 4 weeks, suggesting that hypoxic culture promoted vessel formation in the scaffold
periphery. At 8 weeks, a shift towards greater infiltration (i.e. rightwards) was observed for both
the 2% O2 dynamic and 20% O2 dynamic groups, suggesting that dynamic culture enhanced the
12
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number of vessels infiltrating into the 100 – 200 µm depth range, with a higher number of
vessels in the 2% O2 dynamic group in this range, as well as farther into the scaffolds.
Interestingly, the distributions for the freshly-seeded and unseeded groups were similar at both
timepoints, indicating that the ASCs had little impact on vessel formation within the DAT under
the conditions in this study. While the distribution for the 20% O2 static group was similar to
these groups at 4 weeks, an increase in the number of vessels within the first 50 µm was
observed in this group at 8 weeks, suggesting that there was some benefit of culturing the ASCs
on the scaffolds prior to implantation in terms of vessel formation within the most peripheral
regions of the DAT scaffolds (Figure 5).
DAT scaffolds cultured within the bioreactor for 14 days under hypoxic conditions showed
enhanced adipose tissue remodeling at 8 weeks following subcutaneous implantation
Immunohistochemical staining for perilipin was performed to identify adipocytes containing
intracellular lipid as a measure of adipose tissue remodeling within the implanted scaffolds at 4
(Supplemental Figure 5) and 8 weeks (Figure 6A). At 4 weeks, a small number of adipocytes
were observed within the peripheral regions of the scaffolds in all of the groups. At 8 weeks,
there were qualitatively more adipocytes in the scaffolds that incorporated ASCs as compared to
the earlier timepoint, with more perilipin+ cells observed in the 2% O2 dynamic group as
compared to all other conditions.
Semi-quantitative image analysis confirmed that the relative levels of perilipin expression within
the implant region were similar between the groups at 4 weeks (Figure 6B). In contrast, at 8
weeks, the 2% O2 dynamic group showed significantly greater perilipin expression levels as
compared to all other groups at both 4 and 8 weeks, with a significant increase observed within
this group from 4 to 8 weeks. Collectively, these findings are indicative of enhanced remodeling
13
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of the DAT implant into adipose tissue in the 2% O2 dynamic condition. Further, perilipin
expression was significantly higher in the 20% O2 dynamic group relative to the unseeded and
freshly-seeded groups at both 4 and 8 weeks, as well as the 2% O2 static group at 4 weeks
(Figure 6B).
Human ASCs were detected in the DAT implants at similar levels at both 4 and 8 weeks
Immunohistochemical staining was performed for human-specific Ku80 to identify human ASCs
within the DAT implants at both 4 (Supplemental Figure 6) and 8 weeks (Figure 7A). Ku80+
cells were visualized throughout the seeded scaffolds at both timepoints. Quantification of the
number of Ku80+DAPI+ cells within the scaffold regions revealed that there were no significant
differences in the density of human ASCs detected between the seeded implant groups at both 4
and 8 weeks (Figure 7B).
No evidence of human ASC differentiation into adipocytes in vivo
Co-staining with a human anti-mitochondrial (hMito) antibody in combination with perilipin was
performed to probe human ASC differentiation into adipocytes within the DAT implants. No
perilipin+hMito+ cells were identified, indicating that the newly-forming adipocytes within the
DAT implants were predominantly host-derived (Figure 8).

Discussion
New strategies that can promote the regeneration of healthy host-derived adipose tissue and
enable stable and predictable volume augmentation would be of great value for a broad range of
applications in plastic and reconstructive surgery. With the long-term goal of advancing towards
clinical translation, our lab has been developing a broad range of off-the-shelf bioscaffolds
14
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derived from the ECM of human adipose tissue7,8,35–37. Our previous in vivo study exploring
DAT scaffolds in a subcutaneous implant model in immunocompetent rats indicated that seeding
the DAT with allogeneic rat ASCs significantly enhanced blood vessel formation and remodeling
of the DAT into host-derived adipose tissue13. In that study, the DAT scaffolds were seeded with
the ASCs within tissue culture inserts and then cultured statically for 72 h to promote cell
attachment. However, these static seeding and culture methods result in a heterogeneous and
sparse distribution of ASCs on the relatively dense intact DAT scaffolds, with limited cell
infiltration into the central scaffold regions. We postulated that having a higher density and more
even distribution of cells throughout the scaffold may be favorable for enhancing the rate and
extent of adipose tissue regeneration within the DAT. Further, in the current study, we also
extended from our previous in vivo work by investigating human ASCs as a more clinicallyrelevant cell population.
Dynamic culture methods can enhance cell proliferation and infiltration into 3-D porous
scaffolds by promoting the exchange of nutrients and waste, as well as by providing mechanical
stimulation that can modulate cell function38–40. Stirred culture systems, such as spinner flasks,
have been most extensively explored for the expansion of mesenchymal stromal cell (MSC)
populations including ASCs, incorporating a range of microcarrier types to support cell
attachment and growth41–47. Using an alternative design, Papadimitropoulos et al. investigated
the use of a ceramic scaffold-based perfusion bioreactor for human bone marrow-derived MSC
expansion48, and Kim and Ma applied a perfusion bioreactor system for the expansion of human
MSCs from bone marrow on polyethylene terephthalate (PET) scaffolds49. In general, the overall
goal in these strategies was to harness the benefits of dynamic culture within a 3-D system to
better preserve MSC function in terms of their capacity to proliferate and differentiate towards
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the adipogenic, osteogenic and/or chondrogenic lineages, as compared to the progressive
functional decline that is observed when the cells are expanded on 2-D tissue culture polystyrene
under static conditions44,50. The cells expanded within these systems can typically be released,
such as through enzymatic digestion, and subsequently incorporated within a range of delivery
platforms depending on the application of interest51,52.
In the current study, an integrated approach was applied using a custom 3-D perfusion bioreactor
to expand the human ASCs on the same DAT scaffold on which they would be delivered. While
similar perfusion bioreactor strategies have been explored for bone tissue engineering
applications using biomaterials with properties that mimic bone51,52, to the best of our knowledge
this is the first study to investigate the use of a scaffold-based perfusion bioreactor for adipose
tissue regeneration. Culturing within the perfusion bioreactor system was shown to enhance the
cell density within the peripheral regions of the DAT scaffolds, with a more marked effect in the
samples that were cultured under 2% O2. These findings supporting the benefits of perfusion
culture are similar to a previous study using a double chamber perfusion bioreactor that
demonstrated that media perfusion enhanced bone marrow-dervied MSC homogeneity within
decelluarized porcine tracheal scaffolds53. Additionally, a study by Sailon et al. showed that that
the density of MC3T3-E1 murine pre-osteoblastic cells was enhanced on porous polyurethane
scaffolds when cultured within a perfusion bioreactor system as compared to static controls, with
the cells typically localized in the more porous regions of the scaffolds54. The enhanced cell
density within the peripheral regions of the DAT suggests that there may have been limited
media perfusion into the central regions of the scaffolds over time, which is a potential
limitation. Regardless, the in vivo findings clearly support that culturing the ASCs on the DAT
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within the perfusion bioreactor under 2% O2 significantly augmented angiogenesis and
adipogenesis within the implants, supporting the benefits of the approach.
Based on the PicoGreen and Ki-67 staining results, culturing under dynamic conditions within
the bioreactor stimulated ASC proliferation on the DAT. Interestingly, there was no benefit of
culturing the scaffolds under static conditions for 14 days in terms of the total cell number per
scaffold relative to the freshly-seeded group. In addition to promoting ASC proliferation,
bioreactor culture may have enhanced long-term cell survival55,56, contributing to the higher cell
density observed. Further, the media used in this study contains both mitotic factors as well as
potent chemotactic factors57,58 that may have promoted cell migration from the scaffold interior
to the more highly perfused periphery.
The ASCs cultured both statically and dynamically under 2% O2 were also shown to express
HIF-1α, consistent with hypoxia in adipose tissue being < 5% O259,60. HIF-1α activation is
associated with MSC proliferation61,62, which may have contributed to the enhanced Ki-67
expression in the hypoxic dynamic group. A previous study by Choi et al. demonstrated that
culturing human ASCs under 2% O2 increased proliferation relative to culture under ~21% O2
through HIF-1α-mediated mechanisms26. In a more recent study, human ASCs were found to be
more proliferative when cultured under 1% O2 as compared to 2% O2 for 7 days31. Moreover, the
increased proliferation was shown to be mediated through the HIF-1α-dependent upregulation of
bFGF31. In addition to stimulating proliferation, HIF-1α is an important transcription factor that
regulates the expression of a range of angiogenic growth factors63. As such, it is possible that
culturing under 2% O2 may have modulated the paracrine factor secretion profile of the ASCs
within the DAT, which would be interesting to explore in future work.
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Following in vitro characterization, in vivo testing was performed to assess the effects of
bioreactor culture on the capacity of the ASCs to promote angiogenesis and adipogenesis within
the DAT. Athymic nude mice, which have been used in a number of adipose tissue engineering
studies64–71, were applied to enable the investigation of human ASCs. Angiogenesis was probed
by quantifying the number of erythrocyte-containing blood vessels within the implants,
indicative of functional vasculature. Previously in the rat model, we found that seeding the DAT
with allogeneic rat ASCs resulted in an increase in the number and diameter of erythrocytecontaining blood vessels within the implants starting at 8 weeks13. In the current study, the vessel
density was significantly higher in the 2% O2 dynamic group at both 4 and 8 weeks as compared
to all other conditions. Since the ASC density at 14 days was significantly higher in this group, it
is possible that enhanced cell delivery may have contributed to increased angiogenesis. A study
by Al-khaldi et al. demonstrated there was a dose-dependent increase in in vivo blood vessel
formation at 28 days when varying densities of mouse MSCs (up to 2 x 106 cells/mL) were
delivered subcutaneously in Matrigel in C57BL/6 mice72. In addition to vessel density, the
increased blood vessel infiltration observed in the hypoxic bioreactor group could be an indicator
of an enhanced vessel sprouting effect. Previous studies have shown that VEGF and bFGF are
key paracrine factors that are crucial in driving vessel sprouting27, which are secreted by ASCs at
enhanced levels under hypoxia29,30. Moreover, there is also evidence to support that MSCs
subjected to shear stress induced by dynamic culturing systems can show enhanced VEGF
secretion19,21. As discussed, it would be worthwhile to explore the effects of dynamic culture on
the DAT on ASC phenotype and paracrine function in future studies.
In addition to enhanced angiogenesis, culturing the ASCs on the DAT within the bioreactor
under 2% O2 for 14 days prior to implantation resulted in a significant increase in the number of
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perilipin+ adipocytes within the implants at 8 weeks as compared to all other groups, consistent
with enhanced remodeling of the DAT into adipose tissue. Adipose tissue regeneration is
typically a gradual process that is coupled with angiogenesis, as a rich vascular supply is
required to support mature adipocytes73,74. In our previous rat study, we found that seeding the
DAT with allogeneic rat ASCs enhanced adipogenesis within the implants at both 8 and 12
weeks13. However, the response at 8 weeks was quite variable, with 20.1 ± 15.3% of the seeded
DAT having remodeled into mature fat, as compared to 3.9 ± 5.7% in the unseeded group, based
on area analysis of Masson’s trichrome stained cross-sections13. The lack of difference observed
between the other ASC-seeded groups in the current study relative to the unseeded controls may
be related to species variability in terms of both the ASC source and animal model employed, as
well as to differences in the ASC dose delivered. In addition, it is possible that further
differences would be observed between the groups at later timepoints. Regardless, our findings
clearly demonstrate that dynamic culture of human ASCs on the DAT within the perfusion
bioreactor under 2% O2 significantly augmented both angiogenesis and adipogenesis within the
implants at 8 weeks, supporting the use of this new strategy for adipose tissue regeneration.
While the density of ASCs was higher on the 2% O2 dynamic scaffolds at the time of
implantation, there were no significant differences between the groups in terms of the number of
human ASCs detected within the implants at both 4 and 8 weeks. It is possible that the enhanced
vascularization observed in the bioreactor-cultured samples may have contributed to this decline
by promoting the recruitment of immune cell populations such as monocytes/macrophages that
may recognize the human ASCs as being foreign. In our previous study, using fluorescence in
situ hybridization (FISH) to track the allogeneic ASCs sourced from male donors via the ychromosome, a progressive reduction in the number of donor cells within the DAT implants was
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observed over time, with only a small number of donor ASCs visualized at 8 weeks and no
positive cells detected at 12 weeks, indicating that the newly-formed adipose tissues were
predominantly host-derived13. Similarly, Parisi-Amon et al. showed that mouse ASCs delivered
subcutaneously in nude mice within a peptide-based hydrogel showed an 80% reduction in
exogenous cells after 7 days in vivo based on bioluminescence imaging75. Additionally, a more
recent study using a poly(N-isopropylacrylamide)-polyethylene glycol co-polymer to encapsulate
human ASCs demonstrated ~13% retention at 14 days following subcutaneous delivery in
athymic nude mice76. The persistence of a relatively high density of human ASCs in the current
study at 8 weeks in all of the seeded groups suggests that the DAT may provide a supportive
platform for their delivery. The functional role of these cells remains unclear, but the staining
patterns suggest that there was limited differentiation into adipocytes. It would be interesting to
explore how long these cells persist in future studies, as well as probing differences in possible
paracrine-mediated effects at later timepoints including host adipogenic progenitor cell
recruitment.

Conclusions
The perfusion bioreactor system represents a novel and promising platform for the dynamic
expansion of pro-regenerative cell populations on 3-D bioscaffolds for adipose tissue
engineering, and also an advancement towards a clinically viable strategy to support adipose
tissue regeneration. The findings in this study demonstrated that the perfusion bioreactor system
is effective at increasing the density of ASCs on the DAT, which suggests that it could address
the previous limitations of the ASC-seeded DAT bioscaffolds. Increasing the ASC density on the
DAT bioscaffolds via culturing within the perfusion bioreactor system under hypoxia
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subsequently translated into an enhanced capacity to support blood vessel formation and adipose
tissue remodelling in vivo. Collectively, the body of work in the present study provided support
for the use of a perfusion bioreactor system to increase the pro-regenerative potential of the
ASC-seeded bioscaffolds. Moving forward, future studies should explore the mechanisms
through which the ASC-seeded DAT supports angiogenesis and adipogenesis in vivo as the next
step towards developing a clinically-translatable subcutaneous adipose tissue regeneration
strategy.
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Figure 1. ASC density was enhanced on the DAT scaffolds following 14 days of culture
within the perfusion bioreactor under 2% O2. A) Average number of ASCs/scaffold based on
total dsDNA content following 14 days of culture. Dashed line represents the average cell
density in the freshly-seeded group. Error bars represent standard deviation (n=4, N=3). B) The
average number of ASCs per mm2 of the DAT bioscaffold as measured by DAPI quantification
following 14 days of culture. Error bars represent standard deviation (n=3, N=3). * = 2% O2
dynamic is significantly different than 20% O2 static and 2% O2 static group (P<0.05). C)
Representative H&E staining showing the distribution of ASCs on the DAT scaffolds following
14 days of culture. Scale bars represent 100 µm.
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Figure 2. Ki-67 expression at 14 days was enhanced in the ASCs dynamically cultured on
the DAT scaffolds within the perfusion bioreactor under 2% O2. A) Representative images
showing Ki-67+ cells (red) counterstained with DAPI (blue) in the peripheral regions of the
scaffolds after 14 days of culture. White arrowheads denote positively labelled cells and dashed
lines represents the edge of the bioscaffolds. Scale bars represent 100 µm. B) The average
number of Ki-67+DAPI+ cells in the peripheral and central regions of the scaffolds at 14 days.
Error bars represent standard deviation (n=3, N=4). * = significant difference between 2% O2
dynamic group and all other groups, # = significant difference between the central region of 2%
O2 dynamic and 2% O2 static groups (p<0.05).
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Figure 3. HIF-1α expression was enhanced at 14 days in the ASCs cultured on the DAT
scaffolds under 2% O2. A) Representative immunostaining showing HIF-1α+ ASCs (green)
counterstained with DAPI (blue) in the peripheral (< 200 µm from the edge) regions of the
scaffolds following 14 days of culture. Scale bars represent 100 µm. Dashed lines represent the
border of the bioscaffolds. B) The average number of HIF-1α+DAPI+ cells in the peripheral and
central regions of the scaffolds at 14 days. Error bars represent standard deviation (n=3, N=4).
* = significant difference between the peripheral region of the 2% O2 dynamic group and both
the central and peripheral regions of all other groups , # = significant difference between the
central region of the 2% O2 dynamic group and the central region of all other conditions,
Δ = significant difference between the 2% O2 static group as compared to the 20% O2 static and
20% O2 dynamic groups in both regions (P<0.05).
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Figure 4. The density of erythrocyte-containing blood vessels was enhanced at 4 and 8
weeks in the DAT scaffolds that were cultured in the bioreactor under 2% O2 for 14 days
prior to subcutaneous implantation in nu/nu mice. A) Representative Masson’s trichrome
staining of the DAT implants at 8 weeks, with black arrowheads highlighting erythrocytecontaining blood vessels within the scaffolds. Scale bars represent 100 µm. B) Density of
erythrocyte-containing blood vessels within the scaffolds at 4 and 8 weeks. Error bars represent
standard deviation (n=3 cross-sections/implant, N=6 implants per group).* = 2% O2 dynamic
group at 8 weeks is significantly different compared to all groups at both 4 and 8 weeks,
# = significant difference between 2% O2 dynamic group and all other groups at 4 weeks,
Δ = 20% O2 dynamic group is significantly different than the indicated groups at both 4 and 8
weeks (p<0.05).
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Figure 5. Culturing the ASCs on the DAT bioscaffolds modulated blood vessel infiltration
into the DAT implants over time. Frequency distribution plots showing the total number of
erythrocyte-containing blood vessels at increasing depths from the scaffold periphery within the
DAT implants. Coloured lines represent non-linear Gaussian fits of the data sets. Pooled data is
shown representing the combined counts from 3 cross-sections at varying depths from 6 implants
per condition at both 4 and 8 weeks.

33

bioRxiv preprint doi: https://doi.org/10.1101/2020.04.10.036194; this version posted April 23, 2020. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

Figure 6. Remodeling of the DAT into adipose tissue was enhanced in the 2% O2 dynamic
group at 8 weeks following subcutaneous implantation in the nu/nu mouse model.
A) Representative immunostaining showing regions of perilipin+ adipocytes (brown) within the
implanted scaffolds at 8 weeks. Scale bars represent 100 µm. B) The expression of perilipin
relative to the unseeded group at 4 weeks. Error bars represent standard deviation (n=3 crosssections/implant, N=6 implants per group). * = significant difference between the 2% O2
dynamic group at 8 weeks and all other groups at both 4 and 8 weeks, as well as the 2% O2
dynamic group at 4 weeks, # = significant difference between the 20% O2 dynamic group at 8
weeks and the indicated groups (P<0.05).
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Figure 7. Ku80+ cell density was similar between all seeded groups at both 4 and 8 weeks
post-implantation. A) Representative immunostaining showing Ku80 labelled cells (red)
counterstained with DAPI (blue). Scale bars represent 100 µm. B) Bar graph showing the density
of Ku80+DAPI+ ASCs in the implants at 4 and 8 weeks. Data was compiled from 6 implants per
group (N=6), with 3 cross-sections per scaffold taken from varying depths and 10 random fields
analyzed per cross-section. Error bars represent standard deviation.
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Figure 8. Staining patterns suggest that the human ASCs did not differentiate into
adipocytes within the DAT implants over 8 weeks. Representative image showing distinct
hMito+ (red) and perilipin+ (green) cell populations with DAPI (blue) counterstaining. White
arrowheads indicate human ASCs in close proximity to perilipin+ cells. Scale bars represent
50 µm.
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Supplemental Figure 1. Schematic of the perfusion bioreactor system. A) Culture media is
pumped unidirectionally via the peristaltic pump through the sample chamber before being
recycled back into the media reservoir. B-C) The components of the sample chamber (B) and
culture inserts (C).
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Supplemental Figure 2. Representative Ki-67 staining in the central regions of the ASCseeded DAT scaffolds cultured under static or dynamic conditions within the bioreactor for
14 days. Ki-67 expression is shown in red and DAPI counterstaining in blue. Scale bars
represent 100 µm.
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Supplemental Figure 3. Representative HIF-1α staining in the central regions of the ASCseeded DAT scaffolds cultured under static or dynamic conditions within the bioreactor for
14 days. HIF-1α+ cells are shown in green and DAPI counterstaining in blue. Scale bars
represent 100 µm.
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Supplemental Figure 4. The average erythrocyte-containing blood vessel A) diameter and
B) depth of infiltration in the DAT scaffolds following subcutaneous implantation in the
nu/nu mouse model for 4 and 8 weeks. Error bars represent standard deviation (n=3
cross-sections/implant, N=6 implants per group). *=significant difference in the 2% O2 dynamic
group as compared to the unseeded, freshly-seeded and 2% O2 static groups at 8 weeks (p<0.05).
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Supplemental Figure 5. Representative images showing perilipin staining (brown) in the
DAT scaffolds implanted subcutaneously in the nu/nu mouse model for 4 weeks. Scale bars
represent 100 µm.
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Supplemental Figure 6. Representative immunostaining showing Ku80+ (red) human ASCs
counterstained with DAPI (blue) in the DAT scaffolds that implanted subcutaneously in the
nu/nu mouse model for 4 weeks. Scale bars represent 100 µm.
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